Abstract
Age-associated changes in the T cell compartment are well described. However, limitations of current single-modal or bimodal single-cell assays, including flow cytometry, RNA-seq (RNA sequencing) and CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing), have restricted our ability to deconvolve more complex cellular and molecular changes. Here, we profile >300,000 single T cells from healthy children (aged 11–13 years) and older adults (aged 55–65 years) by using the trimodal assay TEA-seq (single-cell analysis of mRNA transcripts, surface protein epitopes and chromatin accessibility), which revealed that molecular programming of T cell subsets shifts toward a more activated basal state with age. Naive CD4+ T cells, considered relatively resistant to aging, exhibited pronounced transcriptional and epigenetic reprogramming. Moreover, we discovered a novel CD8αα+ T cell subset lost with age that is epigenetically poised for rapid effector responses and has distinct inhibitory, costimulatory and tissue-homing properties. Together, these data reveal new insights into age-associated changes in the T cell compartment that may contribute to differential immune responses.
Subject terms: Translational immunology, Cellular immunity, Chromatin analysis, RNA sequencing, Next-generation sequencing
Using TEA-seq, Thomson et al. detail transcriptional and epigenetic alterations in the T cell compartment between healthy children and older adults, leading to the discovery of a novel pediatric CD8αα+ population poised for rapid effector responses.
Main
Increased susceptibility to infectious agents such as influenza A virus and Streptococcus pneumoniae is known to occur at the extremes of age. However, immune responses in children and older adults are not identical, as demonstrated by the markedly higher rates of hospitalization and death from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in older adults1. Naive T cell responses are critical for defense against emerging viral infections and long-lasting, effective vaccine responses; however, differential immunity due to T cell variability between healthy children and adults is not well understood.
A hallmark of immune aging in adults is the loss of naive CD8+ T cells. Studies have demonstrated that the naive CD8+ T cell compartment is also affected by naive-like memory cell infiltration2–4 and pseudodifferentiation toward memory-like epigenetic programming that biases naive CD8+ T cell development into effector phenotypes5,6. In adult mice, naive CD8+ T cells show altered epigenetic programming that favors the formation of memory T cells, whereas naive CD8+ T cells in newborn mice exhibit more innate-like effector responses to infection7,8. Although these mouse studies excluded the naive CD4+ T cell compartment, human naive CD4+ T cells seem less affected by age, with less decline in numbers and fewer molecular changes9. Naive CD4+ T cells exhibit age-related functional differences in antigen-specific responses, preferentially polarizing toward programming of T helper type 2 cells in children10,11. Moreover, naive CD4+ T cells in older adults are epigenetically biased toward effector-like polarization compared to those in younger adults12. This suggests distinct molecular programming directly linked with age in naive CD4+ T cells. A detailed analysis of cellular and molecular heterogeneity within the human CD8+ and CD4+ T cell compartments across age groups is needed to understand differential immune responsiveness.
Most single-cell studies on cellular heterogeneity in humans and mice have been restricted to protein, RNA or chromatin accessibility analysis in a single modality7,8,13,14, limiting the deconvolution of complex cellular alterations that may occur across age. The novel trimodal assay TEA-seq (single-cell analysis of mRNA transcripts, surface protein epitopes and chromatin accessibility) permits simultaneous single-cell analysis in the proteome, transcriptome and epigenome15. This trimodal approach is particularly important for T cells because certain canonical markers can be assessed in only one type of modality, such as protein isoforms, cytokine expression and transcription factor (TF) activity. The ability to differentiate T cell subsets through a combination of three modalities also allows for direct study of the interplay between canonical surface protein phenotypes and transcriptional and epigenetic programs and provides unprecedented, detailed resolution of the complex heterogeneity among T cells.
In this study, we used TEA-seq to dissect the compositional and molecular alterations within the T cell compartment across the spectrum of healthy age. The results showed broad differential transcriptional and epigenetic alterations within the T cell compartment of older adults compared to children. Adult naive CD4+ T cells exhibited a distinct molecular program indicative of low-grade activation despite retaining a surface proteome essentially identical to that in children. The molecular landscape of naive CD8+ T cells was more resilient to aging, but the composition of infiltrating naive-like memory cells differed considerably across age, leading to the discovery of a novel CD8αα+ T cell subset poised for rapid effector responses lost with age (from ~1.5% of T cells in children to <0.05% of T cells in adults). Collectively, these data highlight the complex heterogeneity within the T cell compartment across age. This data resource is also provided at https://explore.allenimmunology.org/explore as an interactive visualization tool for further exploration of human T cells.
Results
Age-related transcriptional and epigenetic changes in T cell subsets
To study T cell heterogeneity across human age, we used TEA-seq to perform deep multi-omic analysis of T cells isolated from the peripheral blood of pediatric (aged 11–13 years, n = 8) and older adult (aged 55–65 years, n = 8) female donors (Fig. 1a). We analyzed a total of 324,255 T cells, including 204,586 CD4+ T cells and 95,832 CD8+ T cells (Fig. 1b). Single-cell RNA sequencing (scRNA-seq) was additionally performed on 541,803 T cells from a cohort of 16 pediatric, 16 young adult (aged 25–35 years) and 16 older adult donors with equal sex distribution (Fig. 1a,b). Antibody-derived tags (ADTs) were used to detect protein abundance and perform cell gating analogous to flow cytometry (Fig. 1c,d and Extended Data Fig. 1a). Nine T cell subsets were defined according to markers described in Supplementary Table 1. ADT-defined T cell subsets were highly correlated with those detected by spectral flow cytometry across all donors (Extended Data Fig. 1b) but differed from those identified by Seurat RNA-based or assay for transposase-accessible chromatin (ATAC)-based label transfer methods, with an average deviation of 29.3% (Extended Data Fig. 2a–c). Combined data from all three modalities indicated that subsets clustered as expected by differentiation states (Fig. 1e).
The frequencies of ADT-defined T cell subsets in children and older adults were consistent with immune aging, including a reduced frequency of naive CD8+ T cells (Fig. 2a). Transcriptional and epigenetic profiles indicated that age corresponded with differences within subsets (for example, within the naive T cell compartment) more than frequency shifts across subsets (for example, from naive to memory) (Fig. 2b). Conversely, cytomegalovirus (CMV) infection, a common confounder in age-related studies, corresponded with frequency shifts across T cell subsets independent of age (Fig. 2c). Age also had a greater impact on the number of differentially expressed genes (DEGs) and differentially accessible ATAC peaks (DAPs) than CMV infection status (Fig. 2d,e). With age, increased numbers of DEGs and DAPs were found across multiple subsets, including both naive CD8+ and CD4+ T cells. CMV infection had little impact on the transcriptional profile and chromatin landscape of naive CD4+ and CD8+ T cells, consistent with previous reports of CMV infection driving the expansion of effector memory T cells but not naive or central memory T cells16. Further pathway analysis of DEGs revealed that older age was associated with downregulation of RNA splicing and oxidative phosphorylation pathways across multiple T cell subsets, whereas CMV infection was associated with downregulation of tumor necrosis factor (TNF) signaling and upregulation of the natural killer (NK) cell cytotoxicity pathway in effector populations (Fig. 2f). Epigenetically, the binding motifs for the TFs FOS and JUN were more accessible, whereas those for nuclear factor-κB (NF-κB) subunit 1 (NFKB1) and the proto-oncoprotein REL were less accessible, in adult T cells (Fig. 2g). No TF binding motif enrichment was associated with CMV infection, in line with CMV driving few epigenetic changes across T cell subsets. Thus, age-specific, global molecular alterations exist in the T cell compartment of children and adults.
Dynamic molecular reprogramming of naive CD4+ T cells across age
Naive CD4+ T cells in adults are believed to be relatively resistant to aging9; however, we observed the most age-related epigenetic changes in this subset compared to all other T cell subsets. This led to the question of whether naive CD4+ T cells may be composed of different subsets and/or demonstrate a distinct molecular program in children compared to adults. To investigate these hypotheses, we performed unsupervised clustering of the ADT-defined naive (CD45RA+C–C motif chemokine receptor 7 (CCR7)+CD27+) CD4+ T cells (99,501 total cells) based on a three-way weighted nearest-neighbor (3WNN) method using a combination of ADT, RNA and ATAC data (Fig. 3a). Subsets identified within the naive CD4+ T cell compartment included true naive T cells (CD49d[ADT]−FAS[RNA]−interferon-γ (IFNγ)[ATAC]−), stem cell memory (SCM) cells (CD49d[ADT]+FAS[RNA]+IFNγ[ATAC]+) and CD25− regulatory T (Treg) cells (FOXP3[RNA]+CD25[ADT]−IL2RA[RNA]+) (Fig. 3b,c). An increased frequency of CD4+ SCM cells (4.2% in children, 9.2% in adults; adjusted P value (Padj) = 0.03) and a decreased frequency of CD25− Treg cells (3.4% in children, 1.9% in adults; Padj = 0.03) were observed in adults compared to children. These shifts accounted for a 3.5% increase within the overall naive CD4+ T cell compartment in adults. True naive CD4+ T cells had no significant change in frequency across age (92.3% in children, 88.2% in adults; Padj = 0.23) (Fig. 3d).
We next assessed age-related differences in the surface proteome, transcriptome and epigenome within naive CD4+ T cell subsets. Clustering of cells based on surface proteome alone revealed little difference with age (Fig. 3e). However, children showed distinct clustering based on RNA and ATAC profiles (Fig. 3e and Extended Data Fig. 3a,b). True naive CD4+ T cells also had multiple age-related DEGs, with similar numbers within the SCM and CD25− Treg subsets (Fig. 3f), and showed differences in chromatin accessibility across age (Fig. 3g). Analysis of genes enriched in children identified multiple differentially expressed TFs (for example, SOX4, TOX and DACH1) (Fig. 4a), whereas genes enriched in adults shared expression with CD4+ SCM cells, including the peptidase CPQ, the TF STAT4 and the phosphatidylinositol signaling transducer INPP4B (Fig. 4a,b).
We determined whether differential TF expression influences chromatin accessibility. TF motif enrichment across DAPs indicated altered TF usage with age. True naive CD4+ T cells in adults were preferentially biased toward accessibility in regions with TFs related to activation (for example, Krüppel-like factors (KLFs), specific protein 1 (SP1)) and cytokine signaling (for example, IFN regulatory factors (IRFs)) (Fig. 4c,d). Conversely, true naive CD4+ T cells in children had TF motif accessibility associated with NF-κB signaling (for example, RELB, cAMP-responsive element binding protein 1 (CREB1)) and transforming growth factor-β signaling (for example, SOX4). These data indicate that true naive CD4+ T cells are transcriptionally and epigenetically distinct in children and older adults.
To better understand the dynamics of true naive CD4+ T cell reprogramming across age, we performed scRNA-seq on peripheral blood mononuclear cells (PBMCs) from children (n = 16), young adults (n = 16, aged 25–35 years) and older adults (n = 16). We integrated data from an available cord blood scRNA-seq dataset (Fig. 4e). A total of 124,564 naive CD4+ T cells were identified using Seurat’s reference-based RNA label transfer method, which had a 90% agreement with our TEA-seq ‘true’ naive CD4+ T cell designations (Extended Data Fig. 2d), in contrast to 76% agreement with the ADT-only naive CD4+ T cell designations (Extended Data Fig. 2b). Naive CD4+ T cells from children clustered separately from those from both young and older adults (Fig. 4f). Naive CD4+ T cells from young and older adults also exhibited more similar gene expression patterns compared to naive CD4+ T cells from children (Extended Data Fig. 3c). Consistent with this, two pediatric-signature genes, TOX and SOX4, were highly expressed in naive CD4+ T cells from cord blood but showed decreased expression with age, whereas older adult-signature genes (for example, CPQ, STAT4) demonstrated a stepwise increase with age (Fig. 4g). These changes were also confirmed by bulk reverse transcription followed by qPCR (Extended Data Fig. 3d). Together, these data demonstrate that the pediatric-specific molecular programming of true naive CD4+ T cells arises early in life and gradually shifts toward a transcriptionally and epigenetically distinct state in adults.
Age-specific reorganization of naive-like memory CD8+ T cells
Compositional heterogeneity in ‘naive’ CD8+ T cells is known to change during adult aging with an expansion of CD8+ SCM and memory-like naive precursor (MNP) populations3,4,17. However, whether these compositional changes extend to the naive CD8+ T cell compartment of children is unclear. Using unsupervised reclustering of ADT-defined naive CD8+ T cells (46,122 total cells), we identified five cell subsets within the naive CD8+ T cell compartment: true naive T cells (CD49d[ADT]−FAS[RNA]−IFNγ[ATAC]−), SCM cells (CD49d[ADT]+FAS[RNA]+IFNγ[ATAC]+), two MNP populations (MNP-1 and MNP-2, CD49d[ADT]hiFAS[RNA]lowIFNγ[ATAC]low/+) and mucosal-associated invariant T cells (MAIT; T cell receptor (TCR) Vα7.2[ADT]+ and CD161[ADT]+) (Fig. 5a–c). The frequencies of the CD8+ SCM (2.1% in children, 8.8% in adults; Padj = 0.02) and CD8+ MNP-1 (3% in children, 7.3% in adults; Padj = 0.003) T cell subsets increased with age (Fig. 5d). However, the frequency of the CD8+ MNP-2 subset significantly decreased with age (3.3% in children, 0.8% in adults; Padj = 0.0008). No difference in true naive CD8+ T cells or naive MAIT CD8+ T cells was observed. Overall, the frequency of naive-like memory CD8+ T cells increased from ~9% in children to ~19% in adults (Fig. 5e), contrary to small shifts in the CD4+ compartment.
The unexpected age-related heterogeneity in naive-like memory T cells included a novel pediatric-specific population that we termed ‘MNP-2’. We next analyzed the molecular relationship of this unique subset to the entire T cell compartment. Other naive-like memory populations (SCM and MNP-1) clustered with memory subsets, whereas MNP-2 cells grouped with a distinct, unknown cluster of T cells (Fig. 5f). The SCM and MNP-1 subsets also showed high similarity to memory CD8+ T cells in individual ATAC and RNA analyses (Fig. 5g and Extended Data Fig. 4a). scRNA-seq revealed that all naive-like memory CD8+ subsets expressed naive-like transcription and quiescence factors such as LEF1, BACH2 and FOXP1; however, each subset also expressed a unique profile of integrins, NK surface receptors, TFs and effector molecules (Fig. 5h and Supplementary Table 2). All naive-like memory subsets exhibited enriched TF motif accessibility related to increased effector function, such as the eomesodermin (EOMES) and T-box 21 (TBX21; also known as T-bet) motifs, compared to true naive CD8+ T cells (Extended Data Fig. 4b–d). However, the MNP-2 subset was distinctly enriched for the KLF and SP motifs, whereas the SCM and MNP-1 subsets were more significantly enriched for the JUN/FOS motifs (Extended Data Fig. 4d), suggesting that MNP-2 cells are distinct from the classic memory CD8+ T cell subsets.
To confirm the age-related dynamics of MNP-2 cells, we used the gene expression signature (KLRC3+LEF1+CD8A+) of these cells to identify them in our scRNA-seq dataset (Fig. 5i). Consistent with our TEA-seq analysis, the median MNP-2 cell frequencies showed a ~10-fold reduction with age, decreasing from 1.6% in children to 0.04% in older adults (Fig. 5j). Thus, we found an age-specific restructuring of naive-like memory T cell subsets within the ‘naive’ CD8+ T cell compartment, highlighted by the loss of a unique, previously undescribed naive-like memory T cell subset in adults.
A novel subset of CD8αα+ T cells in children lost with age
The identification of a pediatric-specific, naive-like memory subset was unexpected. Given the uniquely high expression of KLR transcripts in MNP-2 cells, we hypothesized that these cells are innate-like T cells. To assess this, we reanalyzed our TEA-seq dataset in situ to identify all MAIT cells (TCR Vα7.2[ADT]+ and CD161[ADT]+, 9,948 cells) as well as Vδ1+ and Vδ2+ γδ T cells (TRGC1[RNA]+ or TRGC2[RNA]+ and TRGDC[RNA]+, 12,630 cells with 4,451 TRDV1[RNA]+ (Vδ1+) and 8,179 TRDV2[RNA]+ (Vδ2+) cells) among CD3+ T cells (Fig. 6a). 3WNN clustering of these populations revealed that the MNP-2 subset is similar to a subpopulation of lymphoid enhancer-binding factor 1 (LEF1)hiVδ1+ γδ T cells, also specifically enriched in children (Fig. 6b and Extended Data Fig. 5a,c). However, MNP-2 cells did not express γδ TCR genes (TRGC2[RNA]+, TRDC[RNA]+, TRDV1[RNA]+, TRDV2[RNA]+) or MAIT TCR (TCR Vα7.2[ADT]+). Meanwhile, they expressed TRGC1 and αβ TCR genes (TRAC[RNA]+TRBC2[RNA]+), in line with the gene signatures of unconventional CD8+ T cells (Fig. 6c). MNP-2 cells did not express protein or RNA for the classic NK T cell marker CD56 (NCAM1 gene; Fig. 6c) or show CMV-specific enrichment (Extended Data Fig. 5b) but expressed similar RNA levels of NKG7 as the MAIT and γδ T cell subsets (Fig. 6d). Notably, RNA expression of CD8A in the absence of CD8B expression (Fig. 6d) suggests that MNP-2 cells may be a CD8αα+ population distinct from classic innate-like subsets.
We next integrated our MNP-2 dataset with a pediatric thymus scRNA-seq dataset that identified a new subset of thymic CD8αα+ T cells18. Unlike the majority of pediatric MAIT and γδ T cells, MNP-2 cells clustered closely with thymic-derived T cells (Fig. 6e). Notably, MNP-2 cells were most similar to the thymic ZNF683-expressing CD8αα+ subtype but retained much higher levels of the interleukin-21 (IL-21) receptor (IL21R) (Fig. 6e–g). In silico reanalysis of key surface protein markers of the MNP-2 population revealed high IL-21R, CD244 and CD11b coexpression (Extended Data Fig. 6a–c). Transcriptional analysis of CD244+CD11b+CD8+ T cells from cord blood confirmed a CD8αα+ T cell gene signature (Extended Data Fig. 6d). Moreover, the surface protein profile of MNP-2 cells, which showed a CD8αhiCD8βlow phenotype (Extended Data Fig. 6e), was distinct from that expressed by activated naive CD8+ T cells over time (Extended Data Fig. 7), suggesting that MNP-2 cells are a unique population of CD8αα+ T cells in children.
As the variable range of MNP-2 cell frequencies implied compositional diversity, we further examined MNP-2 heterogeneity. Integrated reanalysis of the MNP-2 cluster (2,804 total cells) in our TEA-seq dataset revealed multiple CD8αα+ T cell clusters in children that were globally lost with age (Fig. 6h). Chromatin accessibility analysis showed that the three main transcriptionally distinct clusters (that is, 1, 2 and 3) were epigenetically similar (Fig. 6i). Moreover, these clusters exhibited key RNA features of the original MNP-2 population, including high expression of KLRC2, IL21R and LEF1 (Fig. 6j and Extended Data Fig. 8a). Remaining clusters were identified as MME[RNA]+PD-1[ADT]hi, CR1[RNA]+ and two subsets of CD4+ T cells (Extended Data Fig. 8a–c). IL-21Rhi MNP-2 cells were present in three different states, highlighted by the RNA expression of different functional markers, including granzyme K (GZMK), granulysin (GNLY) and the integrin ITGB1 (Fig. 6j and Extended Data Fig. 8b). However, these populations maintained many similarities, including high expression of TFs related to naivety (for example, FOXP1, LEF1) and effector function (for example, TBX21) (Fig. 6k and Extended Data Fig. 8b). MNP-2 heterogeneity was similar among pediatric donors; however, children with CMV infection trended toward having a greater reduction in the frequency of ‘resting’ MNP-2 cells (Extended Data Fig. 8d,e). Collectively, these data demonstrate the presence of multiple types of CD8αα+ T cells in children, with a dominant CD244+CD11b+ ‘MNP-2’ population.
MNP-2 cells are poised for memory-like effector responses
Given the high basal expression of IL-21R in MNP-2 cells (Fig. 5h and Extended Data Fig. 6), we investigated the functional capacity of this population to respond to IL-21 stimulation through CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing) analysis of pediatric CD8+ T cells (n = 4 donors) (Fig. 7a), allowing simultaneous interrogation of naive, MNP-2 and memory CD8+T cells, as well as MAIT and γδ T cells, before and 4 h after stimulation (Fig. 7b). All subsets demonstrated a transcriptional response to IL-21 stimulation, including upregulation of the cytokine signaling-related genes JAK3, STAT3 and SOCS1 (Fig. 7c and Extended Data Fig. 9a). Gene expression patterns in the MNP-2 and memory subsets were distinct from those in naive CD8+ T cells, including the highest expression of BCL6 in MNP-2 cells (Fig. 7d,e). The phenotypic profile of MNP-2 cells was also distinct from that of virtual memory cells (Extended Data Fig. 9b)19,20. Like other memory T cell populations, MNP-2 cells upregulated the cytolytic molecule PRF1 in response to IL-21 stimulation (Fig. 7e), suggesting a cytotoxic role in specific IL-21-rich tissue contexts.
We next compared early functional responses to direct TCR stimulation (anti-CD3/anti-CD28 beads) (that is, what a T cell does do in response to an antigen) and phorbol 12-myristate 13-acetate plus ionomycin (PMA/iono) activation (that is, what a T cell could do in response to an antigen) (Fig. 8a,b). Indicative of global activation, all T cell subsets from the four donors had upregulated expression of CD69 (Extended Data Fig. 10a,b). MNP-2 cells exhibited transcriptional changes reflective of memory CD8+ T cells, with a small set of unique TCR-induced genes compared to other subsets (Fig. 8c). MNP-2 cells lacked upregulation of genes involved in RNA metabolism, unlike both naive and memory cells (Extended Data Fig. 10c). After TCR stimulation, pediatric memory CD8+ T cells had increased IFNG expression, whereas MNP-2 cells had significantly lower expression of IFNG (Fig. 8d and Extended Data Fig. 10d). The limited IFNG expression was not due to these cells exhibiting exhausted (that is, T cell immunoglobulin and mucin domain-containing protein 3 (TIM3), lymphocyte activation gene 3 (LAG-3), EOMES, cytotoxic T lymphocyte-associated protein 4 (CTLA-4)) or senescent (CD57, killer cell lectin-like receptor G1 (KLRG1), CD85j) protein or RNA signatures (Extended Data Fig. 10e)21. However, MNP-2 cells lacked surface expression of the CD28 costimulatory receptor (Extended Data Fig. 10f) and thus cannot respond to costimulatory signals provided by anti-CD3/anti-CD28 beads, indicating differential TCR signaling in MNP-2 cells.
To bypass any potential altered regulation of the TCR complex, we next performed stimulation with PMA/iono. We found an ~84-fold increase in IFNG expression with stimulation (Fig. 8d,e and Extended Data Fig. 10d) and similar increases in other effector-related genes such as CCL3, CCL4, CCL5 and CSF2 (Extended Data Fig. 10g). Although their responses were more similar to those of memory rather than naive cells (Fig. 8c,d), MNP-2 cells were not polyfunctional, as demonstrated by the absence of other effector molecules such as TNF, IL2 and GZMB after stimulation (Fig. 8d,e) and consistent with upregulated expression of SPRY2, a known suppressor of polyfunctionality (Extended Data Fig. 10d)22. MNP-2 cells also exhibited the strongest upregulation of the costimulatory receptor 4-1BB (that is, TNFRSF9 RNA and CD137 protein) and the mucosal tissue-homing molecule CRTAM (Fig. 8e and Extended Data Fig. 10h). Thus, MNP-2 cells are poised to rapidly express IFNG in response to antigens but not intrinsically polyfunctional like the classic memory CD8+ T cells in children.
The poised effector state of MNP-2 cells in conjunction with features of tissue homing leads to the question of whether this population may have a role in immunity against infection and/or in inflammation. Although scRNA-seq studies on children are limited, we were able to detect MNP-2 cells using our TEA-seq-defined signature in children with SARS-CoV-2-associated multisystem inflammatory syndrome (MIS-C)23 (Fig. 8f). Children with active MIS-C had a markedly decreased frequency of MNP-2 cells compared to healthy controls (Fig. 8g). Moreover, children with more severe disease had even lower MNP-2 cell frequencies than those with moderate disease, with levels rebounding after recovery (Extended Data Fig. 10i). Analysis of TCR gene usage also revealed a broad repertoire in MNP-2 cells in children (Extended Data Fig. 10j), indicating that MNP-2 cells are a diverse population of T cells that are recruited to sites of active inflammation and may contribute to immune resolution within tissues in children.
Discussion
Aging has a profound impact on T cells; however, our understanding of the complexity of this impact across the age spectrum is limited. Here, we used TEA-seq to simultaneously interrogate the cellular and molecular heterogeneity of the T cell compartment in children and adults. We established that age considerably affects the composition, transcriptome and epigenome across T cell subsets in contrast to CMV infection, which preferentially affects composition due to expansion of effector populations. Detailed interrogation of naive T cell subsets revealed substantial molecular reprogramming in the CD4+ compartment, whereas the CD8+ compartment exhibited compositional changes driving age-related differences, including the loss of a unique effector CD8αα+ T cell subset in adults.
Immune aging is marked by the numerical loss of naive CD8+ T cells; however, more recent studies have indicated that memory cell infiltration, pseudodifferentiation and clonal expansion occur24. Our multimodal analysis allows simultaneous analysis of composition, memory infiltration and pseudodifferentiation in the naive CD8+ and CD4+ T cell compartments of children compared to adults. We found that true naive CD4+ T cells are the most affected by age, exhibiting distinct transcriptional and epigenetic programming in children and adults. Pediatric naive CD4+ T cells are primarily present in a cellular state indicative of quiescence, whereas adult naive CD4+ T cells are biased toward an activated state. The subtlety of this change in cell state, in the absence of major alterations in their ‘naive’ program, is similar to findings of recent studies in the field of stem cell aging, in which quiescent stem cells were found to shift into a more readily activated state upon bystander exposure to the aging microenvironment25,26. This cellular priming leads to reduced pluripotency in stem cells, suggesting that reprogramming of naive CD4+ T cells across age may also affect their differentiation potential and be related to dysfunction noted in advanced aging12.
This omics dataset also demonstrates that the differentiation-related transcription and epigenetic signatures found in previous bulk genomic studies of naive CD8+ T cell aging5 are consistent with the molecular profiles of age-expanded naive-like memory CD8+ populations and in line with minimal evidence of pseudodifferentiation in highly purified naive CD8+ T cells from young adults compared to those from older adults27. However, our data also reveal that memory T cell infiltration is not the sole driver of naive CD8+ T cell aging but that a specific reorganization within the ‘naive’ CD8+ T cell compartment occurs between childhood and adulthood. This reorganization is characterized by the ‘loss’ of a previously undescribed IL-21RhiCD244hiCD11bhi population of CD8αα+ T cells in adults. Indeed, this unique MNP-2 subset composed <0.05% of the adult T cell compartment but was heterogeneous and exhibited a broad TCR repertoire in children—all factors that likely contributed to the lack of previous identification. MNP-2 cells also exhibit more stem-like features28 with enrichment of naive TFs (for example, LEF1), distinguishing them from other types of unconventional CD8+ T cells described in adults that expand during chronic viral infection, acute infection and/or autoimmunity and exhibit distinct phenotypes (for example, terminally differentiated, regulatory)29–31.
The marked loss of MNP-2 cells in the periphery of children with active MIS-C suggests that these cells home to tissue sites during an active inflammatory response. Although they exhibit limited polyfunctionality, MNP-2 cells are poised to produce both IFNγ and perforin under specific stimulatory conditions; thus, they may contribute directly to local immune response within tissue sites32. Their tissue-homing properties may also explain their loss in the periphery with age, as thymic production wanes and low-grade tissue inflammation increases33. In advanced aging, the development of memory T cells is impaired, favoring effector cell generation6,12. Conversely, MNP-2 cells appear biased toward memory generation at the cost of superior effector functions, based on their high expression of BCL6 after stimulation34. Further studies into the antigen specificity and responses of this unconventional CD8αα+ T cell population and its importance in tissue-specific immunity and resolution of inflammation across diverse pediatric populations are warranted.
Collectively, these experiments demonstrate a heterogeneous naive T cell compartment in humans, with the CD8+ and CD4+ T cell subsets differentially influenced by age. These variations may have translational implications in the context of infection, vaccination and therapeutic intervention, as overall T cell responses may differ between children and adults. We also demonstrated the potential of TEA-seq as a powerful discovery platform to further enhance our understanding of T cell subsets in many autoimmune and/or inflammatory disease states, such as rheumatoid arthritis, human immunodeficiency virus infection and obesity, to facilitate the identification of molecular drivers of T cell dysfunction for therapeutic targets.
Methods
Adult and pediatric cohorts
Cohort demographics are provided in Supplementary Table 3. Healthy 25- to 35-year-old and 55- to 65-year-old adult donors were recruited from the greater Seattle area as part of the Sound Life Project, a protocol approved by the institutional review board (IRB) of the Benaroya Research Institute. Donors were excluded from enrollment if they had a history of chronic disease, autoimmune disease, severe allergy or chronic infection. Meanwhile, healthy 11- to 13-year-old pediatric donors were recruited from the greater Philadelphia area under a protocol approved by the IRB of the Children’s Hospital of Philadelphia. Donors were excluded from enrollment if they had a history of immune deficiency, fever or antibiotic use within the month before sample collection, chronic medication use, or a body mass index >2 s.d. above or below the mean for their age. All adult participants provided informed consent before participation. Informed consent for the participation of minors was obtained from a legally authorized representative of the child. If capable, the participating child also provided assent to participate in the study. All samples were collected, processed to PBMCs through a Ficoll-based approach and frozen in FBS with 10% dimethyl sulfoxide (DMSO) within 4 h of blood draw. Cord and peripheral blood samples for follow-up studies were purchased from Bloodworks Northwest and BioIVT, with written informed consent and approval by the Allen Institute IRB.
TEA-seq
For TEA-seq experiments, eight pediatric and eight older adult female donors were selected (Fig. 1b). Half the pediatric and adult donors were CMV-positive based on testing in a Clinical Laboratory Improvement Amendments-approved laboratory. TEA-seq library preparation was performed as described previously15, with the addition of Cell Hashing36 to allow for sample multiplexing and limit well-to-well batch effects. In brief, samples were thawed and processed across three batches, with each batch containing a common PBMC control. Antibody staining for Cell Hashing and cell sorting was performed simultaneously on 2 × 106 cells from each sample. Each sample was incubated with a sample-specific barcoded TotalSeq-A antibody, anti-CD45 antibody and anti-CD3 antibody. The samples were then pooled by T cell proportions previously determined by flow cytometry, targeting 800,000 T cells for each donor sample and 200,000 T cells for the control, and sorted on a BD FACSAria Fusion flow cytometer (BD Biosciences). T cells were sorted as live single CD45+CD3+ cells; 2 × 106 sorted T cells were then used for library preparation. A panel of 55 target-specific barcoded oligonucleotide-conjugated antibodies (BioLegend TotalSeq-A) was used for these studies (Supplementary Table 3). Individual ATAC, RNA, hashtag oligonucleotide (HTO) and ADT libraries were prepared, sequenced and processed as described previously15.
TEA-seq data preprocessing
ADT and HTO count matrices were generated using BarCounter (v1.0) (refs. 37). The RNA and ADT count matrices were then combined into a single Seurat object. Cells were selected based on the following cutoffs: >250 genes per cell, >500 RNA unique molecular identifiers (UMIs) per cell, <10,000 ADT UMIs per cell, <35% mitochondrial reads and <20,000 RNA UMIs per cell. Normalization, feature selection and scaling were performed on the RNA matrix (Seurat SCTransform function, default settings), followed by principal component analysis (PCA; Seurat RunPCA function, default settings). A UMAP projection was generated (Seurat RunUMAP, dims = 1:30), and clustering was performed (Seurat FindNeighbors (dims = 1:30), followed by Seurat FindClusters (resolution = 0.5)). We used the Seurat Multimodal Reference Dataset for PBMCs (available from the Satija laboratory, New York Genome Center38) to perform label transfer on the dataset by using the functions described in the Seurat (v4) vignettes (Seurat FindTransferAnchors, followed by Seurat TransferData). Two clusters were identified to be non-T cells and excluded from downstream analysis. Sample-specific transcripts, AC105402.3 and MTRNR2L8, were identified and removed before further downstream RNA analysis.
ADT-based cell type identification
We used CD4, CD8, CD197, CD27 and CD45RA ADT markers to identify T cell subsets. For subset identification, each of the three batches was separated into its own Seurat object before analysis to account for differences in sequencing depth and average ADT UMIs per cell. ADTs were normalized and cells were identified based on the markers outlined in Fig. 1 and Supplementary Table 1 using Boolean gating.
ADT, RNA and ATAC label transfers
RNA-based label transfer was performed using single-positive T cell subsets from the Seurat reference described above and using the Seurat functions FindTransferAnchors and TransferData. Label transfer from ATAC data was performed using the same reference, based on ArchR (v1.0.2) documentation (https://archrproject.com)39. A first round of unconstrained integration was performed, and cells were labeled based on the Seurat L1 cell types. The second round of labeling then used the constrained approach to transfer the L2 cell types within the groups identified in the L1 integration. To directly compare the results from both RNA and ATAC label transfers with our ADT-defined populations, select cell types were merged manually.
TEA-seq T cell subset analyses
3WNN clustering
We performed PCA on both RNA and ADT count matrices and corrected for potential batch effects using Harmony (https://github.com/immunogenomics/harmony)40. For ATAC, a latent semantic indexing (LSI) embedding was calculated in ArchR (ArchR addIterativeLSI function, varFeatures = 75,000), and batch correction was performed (ArchR addHarmony function, groupBy = ‘batch_id’). The corrected LSI embedding was transferred to the Seurat object for 3WNN integration and clustering on all Harmony-corrected principal components and LSI dimensions (Seurat FindMultiModalNeighbors function, dims.list = list(1:25, 1:20, 1:29) for RNA, ADT and ATAC, respectively).
RNA modality analysis
DEG analysis was performed with the hurdle model implemented in the MAST package41. Pvalues were adjusted for multiple comparisons using the Benjamini–Hochberg method42. Padj < 0.05 and log(fold change) > 0.1 were considered significant.
ATAC modality analysis
LSI, clustering, group coverage computation, reproducible peak set annotation (MACS2), motif enrichment and ChromVar deviations enrichment were performed according to the ArchR documentation. The peak matrix was used to identify DAPs between groups. DAPs were used in motif enrichment analysis (ArchR peakAnnoEnrichment function, with cutoffs FDR ≤ 0.1 and log(fold change) ≥ 0.5).
DEG pathway enrichment analysis
Pathway enrichment analysis was performed with GSEA43 implemented in the fgsea package44 to compare adult and pediatric donors and by CMV infection status. A custom collection of gene sets that included the Hallmark (v7.2) gene sets, Kyoto Encyclopedia of Genes and Genomes (v7.2) and Reactome (v7.2) from the Molecular Signatures Database (v4.0) was used as the pathway database, as previously described45. The pathway enrichment Pvalues were adjusted using the Benjamini–Hochberg method, and pathways with Padj < 0.05 were considered significantly enriched.
TF motif analysis
For each ADT-labeled cell type, age group (that is, children versus adults) and CMV infection status were compared to identify DAPs (ArchR getMarkerFeatures function). Motif enrichment (ArchR peakAnnoEnrichment function) was then performed using the resulting DAPs with an FDR cutoff of ≤0.1 and a log2(fold change) cutoff of ≥0.5. Motifs for each cell type were then further filtered by an mlog10(Padj) > 5 cutoff and found to be differentially expressed in at least six of the cell types. As no enriched motifs were detected based on CMV infection status, no plots were generated for visualization.
Naive CD4+ and CD8+ T cell subanalysis
We performed 3WNN clustering, as described above, for ADT-identified CD4+ and CD8+ naive T cells separately. Leiden clusters were then identified at multiple resolutions by varying the resolution parameter of the Seurat FindClusters function from 0.1 to 0.8 and were visualized using the Clustree package46 (https://github.com/lazappi/clustree) to identify the optimal resolution. Marker genes for each cluster were then identified using Seurat’s FindAllMarkers function. ATAC analysis was performed on the same separated populations, using the same approach described above, in ArchR.
Flow cytometry
To assess T cell subset frequencies, PBMCs were analyzed using a 25-color T cell phenotyping flow cytometry panel (Supplementary Table 3), using a standardized method previously published47. Cells were analyzed on a five-laser Cytek Aurora spectral flow cytometer. Spectral unmixing was calculated with prerecorded reference controls using Cytek SpectroFlo software (v2.0.2). Cell types were quantified by traditional bivariate gating analysis performed with FlowJo cytometry software (v10.8).
Power analysis for the confirmatory cohort
The appropriate sample size for the confirmatory cohort was determined according to the minimum sample size required to identify a 1% difference while controlling for type I and type II error rates of 0.05 or 0.02 with an estimated frequency s.d. of 0.45. This resulted in n = 5 per group for a two-sample t-test. Sample size correction based on the asymptotic relative efficiency of the Mann–Whitney U test (that is, 15.7%) resulted in a minimum required sample size of n = 6 per group to identify a 1% difference at 80% power and control for type I and II error rates of 0.05 and 0.2, respectively. Sample size and power calculations do not cover hypotheses beyond the pediatric–older adult cohort comparison.
Confirmatory cohort scRNA-seq
scRNA-seq was performed on PBMCs from 16 pediatric, 16 young adult and 16 older adult donors (Fig. 1b and Supplementary Table 3), as previously described47. In brief, scRNA-seq libraries were generated using a modified 10x Genomics Chromium 3′ single-cell gene expression assay with Cell Hashing. Eight donors were pooled per library, with the addition of a common batch control sample in each library. Libraries were sequenced on an Illumina NovaSeq platform. Hashed 10x Genomics scRNA-seq data processing was carried out using CellRanger (10x Genomics) and BarWare37 to generate sample-specific output files. For scRNA-seq analysis, count matrices from each sample were merged into age-specific Seurat objects, followed by normalization, feature selection, scaling, PCA, UMAP embedding and clustering, as described above. Label transfer from the T cell fraction of the PBMC Seurat reference was performed for each age-specific dataset, as described above. Following label transfer, all objects were merged into a single dataset. Cells identified as naive CD4+ T cells with a prediction score of >0.7 were retained for downstream analysis. We then averaged the expression from each cell in each age group (Seurat AverageExpression function, group.by = ‘age’) for DEGs identified by TEA-seq analysis for use in visualization.
T cell subset sorting
T cells were directly isolated from peripheral or cord blood using the RosetteSep human T cell enrichment cocktail according to the manufacturer’s protocol (Stem Cell Technologies). T cells were cryopreserved in 90% FBS plus 10% DMSO and stored in vapor-phase liquid nitrogen following isolation. Cryopreserved T cells were rapidly thawed and stained with the sorting antibody panel described in Supplementary Table 4. Naive CD4+ T cells were sorted using the FACSMelody cell sorter with FACSChorus (v2.0) software (BD Biosciences), according to the following phenotype: live, single, CD3+CD8−CD4+CCR7+CD45RA+CD27+CD95− cells. A total of 500,000 cells per sample were then pelleted and snap-frozen in dry ice and ethanol for RNA isolation. For MNP-2 subset analysis, 5,000 cells each of MNP-2 and naive CD8+ T cells were sorted, based on the CD244+CD11b+CD8+CD4−CD3+TCRαβ+ and CD244−CD11b−CD8+CD4−CD3+TCRαβ+ phenotypes, respectively, for RNA isolation.
RNA extraction and qPCR
Total RNA was isolated using the RNeasy Plus mini or micro kit (Qiagen) according to the manufacturer’s protocol. cDNA was generated using the SuperScript IV VILO Master Mix (Invitrogen). TaqMan probe sets (Supplementary Table 5) were used for qPCR using the TaqMan Fast Advanced Master Mix on the Bio-Rad CFX96 real-time instrument. All genes were normalized to the housekeeping gene RPLP0, and gene expression levels were compared using the 2(−ΔCt) method.
MNP-2 functional studies
PBMCs and cord blood mononuclear cells (CBMCs) were isolated from peripheral blood samples using standard Ficoll-Paque separation, cryopreserved in 90% FBS plus 10% DMSO and stored in vapor-phase liquid nitrogen. T cells were enriched from cord blood using the RosetteSep human T cell enrichment kit (Stem Cell Technologies).
Naive CD8+ T cell activation
CBMCs or enriched cord blood T cells were enriched for naive CD8+ T cells using the Naive CD8+ T Cell Isolation kit (Stem Cell Technologies) according to the manufacturer’s protocol. Naive CD8+ T cells were plated at 50,000 cells per well in 96-well round-bottom tissue culture plates (untreated) and stimulated with Dynabeads Human T Activator CD3/CD28 beads (0.5 beads per cell) for 1, 2, 3 and 7 days before collection and staining for flow cytometry with a T cell activation panel (Supplementary Table 4).
CD8+ T cell responses through CITE-seq
CD8+ T cells were enriched from cryopreserved pediatric PBMCs (four female donors) (Supplementary Table 3) using the EasySep Human CD8+ T Cell Enrichment Cocktail (Stem Cell Technologies) according to the manufacturer’s protocol. Enriched CD8+ T cells were plated at 200,000 cells per well in 96-well round-bottom tissue culture plates (untreated) and incubated for 4 h at 37 °C and 5% CO2 in RPMI 1640 plus 10% FBS with medium alone, IL-21 (50 ng ml−1), PMA/iono (PMA 50 ng ml−1, iono 1 μg ml−1) or Dynabeads Human T Activator CD3/CD28 (0.5 beads per cell, Thermo Fisher Scientific). After 4 h, cells were collected and stained using TotalSeq-B Human Universal Cocktail (BioLegend) following the manufacturer’s protocol. After antibody staining, cells were fixed and quenched according to the 10x Genomics Fixation of Cells and Nuclei for Chromium Fixed RNA Profiling user guide. Cells were fixed for 16 h and 26 min at 4 °C. RNA was barcoded using the Fixed RNA Feature Barcode kit (10x Genomics). Quality control of prepared libraries for sequencing was performed by TapeStation (Agilent) analysis of 1:50 dilutions of each final library in Buffer EB (Qiagen). Libraries were quantified using the Quant-iT PicoGreen dsDNA Assay (Thermo Fisher Scientific). ADT and scRNA-seq gene expression libraries were sequenced using the NovaSeq S2 platform (Illumina) at read depths of 7,500 and 12,500 reads per cell, respectively. A PhiX control library was spiked in at 10%.
Statistical analysis
Statistical analysis was done using GraphPad Prism 9 for macOS (v9.5.0) software. Two-tailed Mann–Whitney tests were used to compare two groups. Two-tailed paired t-tests were used for within-donor comparisons of two populations. A two-tailed Mann–Whitney test with the Holm–Sidak multiple-comparison method was used to compare three or more groups. P values <0.05 were considered statistically significant. No data were excluded from analyses.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Online content
Any methods, additional references, Nature Portfolio reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at 10.1038/s41590-023-01641-8.
Supplementary information
Source data
Acknowledgements
We thank the study participants and the clinical research teams at the University of Pennsylvania, Children’s Hospital of Philadelphia and Benaroya Research Institute for their dedication to this project. We thank the Allen Institute founder, P.G. Allen, for his vision, encouragement and support. We also thank all members of the Allen Institute for Immunology, in particular the facilities and operations teams who helped maintain the productive research environment, as well as the Human Immune System Explorer (HISE) software development team for their constant support. Research reported in this publication was supported by National Institute on Aging award K01AG068373 (C.E.G.) and by the Allen Institute for Immunology. This research was conducted while C.E.G. was a Diamond/American Federation for Aging Research award recipient. Overview figures were created with BioRender.com. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Extended data
Author contributions
Conceptualization: C.E.G., Z.T., E.S., S.R.Z., J.R., L.T.G., G.L.S., A.K.S., C.S., J.H.B., X.L., T.R.T., E.J.W., T.F.B., L.A.V., S.E.H., P.J.S. Methodology: C.E.G., Z.T., E.S., K.H., C.P., S.R.Z., M.-P.P., L.Y.O., A.T.H., C.R.R., V.H., M.W., P.C.G., J.R., J.R.G., S.M., L.T.G., S.V.V., G.L.S., A.K.S., T.R.T., T.F.B., L.A.V., S.E.H., P.J.S. Investigation: C.E.G., Z.T., Z.H., K.H., C.P., M.-P.P., L.Y.O., A.T.H., C.R.R., V.H., M.W., P.C.G., J.R., J.R.G., S.M., J.D., C.J.J., A.R.G., X.L., T.R.T., E.J.W., L.A.V., S.E.H., P.J.S. Visualization: C.E.G., Z.T., Z.H., K.H., M.-P.P., L.Y.O., T.R.T. Funding acquisition: C.E.G., L.A.B., T.R.T., T.F.B., P.J.S. Project administration: J.D., C.J.J., A.R.G., L.A.B., C.S., J.H.B., E.J.W., P.J.S. Supervision: C.E.G., Z.T., L.T.G., S.V.V., G.L.S., T.R.T., P.J.S. Writing—original draft: C.E.G., Z.T., Z.H., K.H., C.P., S.R.Z., P.J.S. Writing—review and editing: C.E.G., Z.T., Z.H., J.R., L.T.G., S.V.V., G.L.S., A.K.S., C.S., J.H.B., T.R.T., E.J.W., T.F.B., L.A.V., S.E.H., P.J.S.
Peer review
Peer review information
Nature Immunology thanks Paul Klenerman and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: L.A. Dempsey, in collaboration with the Nature Immunology team. Peer reviewer reports are available.
Data availability
Raw data will be deposited in the National Center for Biotechnology Information (NCBI) Database of Genotypes and Phenotypes (dbGaP, study identifier phs003400.v1) for controlled access upon peer-reviewed publication. Processed data are deposited in the NCBI Gene Expression Omnibus (GEO) database (series accession no. GSE214546). The external cord blood (accession no. GSE157007) and pediatric MIS-C (accession no. GSE166489) datasets are from the GEO database. The thymus dataset is from ArrayExpress (accession no. E-MTAB-8581). A custom collection of gene sets that included the Hallmark (v7.2) gene sets, Kyoto Encyclopedia of Genes and Genomes (v7.2) and Reactome (v7.2) from the Molecular Signatures Database (v4.0) was used as the pathway database in GSEA analyses. Source data are provided with this paper.
Code availability
Code used for analysis and figure generation in this paper is available on GitHub (https://github.com/aifimmunology/Aging_Tcell_TEA-seq). The TEA-seq visualization tool is directly accessible at https://explore.allenimmunology.org/explore/e53df468-4a8e-49a4-8b6d-525b0f9914ab.
Competing interests
G.L.S. and S.V.V. are current employees of Seagen. All other authors declare that they have no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Peter J. Skene, Claire E. Gustafson.
Change history
1/24/2024
A Correction to this paper has been published: 10.1038/s41590-024-01757-5
Contributor Information
Peter J. Skene, Email: peter.skene@alleninstitute.org
Claire E. Gustafson, Email: claire.gustafson@alleninstitute.org
Extended data
is available for this paper at 10.1038/s41590-023-01641-8.
Supplementary information
The online version contains supplementary material available at 10.1038/s41590-023-01641-8.
References
- 1.Santesmasses D, et al. COVID-19 is an emergent disease of aging. Aging Cell. 2020;19:e13230. doi: 10.1111/acel.13230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Akondy RS, et al. Origin and differentiation of human memory CD8 T cells after vaccination. Nature. 2017;552:362–367. doi: 10.1038/nature24633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Fuertes Marraco SA, et al. Long-lasting stem cell-like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination. Sci. Transl. Med. 2015;7:282ra48. doi: 10.1126/scitranslmed.aaa3700. [DOI] [PubMed] [Google Scholar]
- 4.Gattinoni L, et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 2011;17:1290–1297. doi: 10.1038/nm.2446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Moskowitz DM, et al. Epigenomics of human CD8 T cell differentiation and aging. Sci. Immunol. 2017;2:eaag0192. doi: 10.1126/sciimmunol.aag0192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kim C, et al. Activation of miR-21-regulated pathways in immune aging selects against signatures characteristic of memory T cells. Cell Rep. 2018;25:2148–2162. doi: 10.1016/j.celrep.2018.10.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Smith NL, et al. Developmental origin governs CD8+ T cell fate decisions during infection. Cell. 2018;174:117–130. doi: 10.1016/j.cell.2018.05.029. [DOI] [PubMed] [Google Scholar]
- 8.Reynaldi A, et al. Fate mapping reveals the age structure of the peripheral T cell compartment. Proc. Natl Acad. Sci. USA. 2019;116:3974–3981. doi: 10.1073/pnas.1811634116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hu B, et al. Distinct age-related epigenetic signatures in CD4 and CD8 T cells. Front. Immunol. 2020;11:585168. doi: 10.3389/fimmu.2020.585168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hebel K, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J. Immunol. 2014;192:5160–5170. doi: 10.4049/jimmunol.1302539. [DOI] [PubMed] [Google Scholar]
- 11.Semmes EC, et al. Understanding early-life adaptive immunity to guide interventions for pediatric health. Front. Immunol. 2021;11:595297. doi: 10.3389/fimmu.2020.595297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Zhang H, et al. Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses. Nat. Immunol. 2023;24:96–109. doi: 10.1038/s41590-022-01369-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Elyahu Y, et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci. Adv. 2019;5:eaaw8330. doi: 10.1126/sciadv.aaw8330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mogilenko DA, et al. Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging. Immunity. 2021;54:99–115. doi: 10.1016/j.immuni.2020.11.005. [DOI] [PubMed] [Google Scholar]
- 15.Swanson E, et al. Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq. eLife. 2021;10:e63632. doi: 10.7554/eLife.63632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Klenerman P, Oxenius A. T cell responses to cytomegalovirus. Nat. Rev. Immunol. 2016;16:367–377. doi: 10.1038/nri.2016.38. [DOI] [PubMed] [Google Scholar]
- 17.Pulko V, et al. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses. Nat. Immunol. 2016;17:966–975. doi: 10.1038/ni.3483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Park J-E, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367:eaay3224. doi: 10.1126/science.aay3224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.White JT, et al. Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner. Nat. Commun. 2016;7:11291. doi: 10.1038/ncomms11291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hussain T, Quinn KM. Similar but different: virtual memory CD8 T cells as a memory-like cell population. Immunol. Cell Biol. 2019;97:675–684. doi: 10.1111/imcb.12277. [DOI] [PubMed] [Google Scholar]
- 21.Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 2015;15:486–499. doi: 10.1038/nri3862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Shehata HM, et al. Lack of Sprouty 1 and 2 enhances survival of effector CD8+ T cells and yields more protective memory cells. Proc. Natl Acad. Sci. USA. 2018;115:E8939–E8947. doi: 10.1073/pnas.1808320115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ramaswamy A, et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity. 2021;54:1083–1095. doi: 10.1016/j.immuni.2021.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Goronzy JJ, Weyand CM. Mechanisms underlying T cell ageing. Nat. Rev. Immunol. 2019;19:573–583. doi: 10.1038/s41577-019-0180-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.van Velthoven CTJ, Rando TA. Stem cell quiescence: dynamism, restraint, and cellular idling. Cell Stem Cell. 2019;24:213–225. doi: 10.1016/j.stem.2019.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Gustafson CE. Naïve T cell quiescence in immune aging. Adv. Geriatr. Med. Res. 2021;3:e210015. doi: 10.20900/agmr20210015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Giles JR, et al. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity. 2022;55:557–574. doi: 10.1016/j.immuni.2022.02.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gattinoni L, Speiser DE, Lichterfeld M, Bonini C. T memory stem cells in health and disease. Nat. Med. 2017;23:18–27. doi: 10.1038/nm.4241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Walker LJ, et al. CD8αα expression marks terminally differentiated human CD8+ T cells expanded in chronic viral infection. Front. Immunol. 2013;4:223. doi: 10.3389/fimmu.2013.00223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Konno A, et al. CD8αα memory effector T cells descend directly from clonally expanded CD8α+βhigh TCRαβ T cells in vivo. Blood. 2002;100:4090–4097. doi: 10.1182/blood-2002-04-1136. [DOI] [PubMed] [Google Scholar]
- 31.Li J, et al. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science. 2022;376:eabi9591. doi: 10.1126/science.abi9591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lawand M, Déchanet-Merville J, Dieu-Nosjean M-C. Key features of gamma–delta T-cell subsets in human diseases and their immunotherapeutic implications. Front. Immunol. 2017;8:761. doi: 10.3389/fimmu.2017.00761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Baechle JJ, et al. Chronic inflammation and the hallmarks of aging. Mol. Metab. 2023;74:101755. doi: 10.1016/j.molmet.2023.101755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ichii H, et al. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat. Immunol. 2002;3:558–563. doi: 10.1038/ni802. [DOI] [PubMed] [Google Scholar]
- 35.Luo OJ, et al. Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty. Nat. Aging. 2022;2:348–364. doi: 10.1038/s43587-022-00198-9. [DOI] [PubMed] [Google Scholar]
- 36.Stoeckius M, et al. Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 2018;19:224. doi: 10.1186/s13059-018-1603-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Swanson E, Reading J, Graybuck LT, Skene PJ. BarWare: efficient software tools for barcoded single-cell genomics. BMC Bioinformatics. 2022;23:106. doi: 10.1186/s12859-022-04620-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–3587. doi: 10.1016/j.cell.2021.04.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Granja JM, et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 2021;53:403–411. doi: 10.1038/s41588-021-00790-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 2019;16:1289–1296. doi: 10.1038/s41592-019-0619-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Finak G, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278. doi: 10.1186/s13059-015-0844-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. Methodol. 1995;57:289–300. [Google Scholar]
- 43.Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv10.1101/060012 (2021).
- 45.Talla, A. et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. Preprint at bioRxiv10.1101/2021.05.26.442666 (2021).
- 46.Zappia L, Oshlack A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience. 2018;7:giy083. doi: 10.1093/gigascience/giy083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Genge PC, et al. Optimized workflow for human PBMC multiomic immunosurveillance studies. STAR Protoc. 2021;2:100900. doi: 10.1016/j.xpro.2021.100900. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Raw data will be deposited in the National Center for Biotechnology Information (NCBI) Database of Genotypes and Phenotypes (dbGaP, study identifier phs003400.v1) for controlled access upon peer-reviewed publication. Processed data are deposited in the NCBI Gene Expression Omnibus (GEO) database (series accession no. GSE214546). The external cord blood (accession no. GSE157007) and pediatric MIS-C (accession no. GSE166489) datasets are from the GEO database. The thymus dataset is from ArrayExpress (accession no. E-MTAB-8581). A custom collection of gene sets that included the Hallmark (v7.2) gene sets, Kyoto Encyclopedia of Genes and Genomes (v7.2) and Reactome (v7.2) from the Molecular Signatures Database (v4.0) was used as the pathway database in GSEA analyses. Source data are provided with this paper.
Code used for analysis and figure generation in this paper is available on GitHub (https://github.com/aifimmunology/Aging_Tcell_TEA-seq). The TEA-seq visualization tool is directly accessible at https://explore.allenimmunology.org/explore/e53df468-4a8e-49a4-8b6d-525b0f9914ab.